Most sold healthcare stocks in Q3 2014
See which Healthcare stocks institutional investors trimmed or exited the most in Q3 2014, measured as net reductions in reported share positions from Q2 2014 into Q3 2014. Notable reductions at the top of this list include PFIZER INC (PFE), ABBOTT LABORATORIES (ABT), BRISTOL-MYERS SQUIBB CO (BMY), EXACT SCIENCES CORP (EXAS). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| PFE | PFIZER INC | -13,295,744 | -$399.91M | 0 | 4 | 6 | 1 | 12 |
| ABT | ABBOTT LABORATORIES | -3,498,569 | -$122.34M | 0 | 3 | 6 | 2 | 12 |
| BMY | BRISTOL-MYERS SQUIBB CO | -2,171,040 | -$102.83M | 1 | 2 | 2 | 0 | 8 |
| EXAS | EXACT SCIENCES CORP | -2,000,000 | -$34.06M | 0 | 0 | 0 | 1 | 0 |
| EXEL | EXELIXIS INC | -1,658,150 | -$5.62M | 0 | 0 | 0 | 1 | 0 |
| REGN | REGENERON PHARMACEUTICALS | -1,515,762 | -$298.66M | 0 | 2 | 1 | 0 | 3 |
| GERN | GERON CORP | -1,350,000 | -$6.99M | 0 | 0 | 1 | 0 | 1 |
| MRK | MERCK & CO. INC. | -1,289,686 | -$18.67M | 1 | 1 | 9 | 0 | 15 |
| MYGN | MYRIAD GENETICS INC | -1,273,300 | -$35.81M | 0 | 2 | 0 | 1 | 3 |
| UHS | UNIVERSAL HEALTH SERVICES-B | -1,227,443 | -$117.10M | 1 | 0 | 0 | 1 | 1 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -934,125 | -$20.11M | 0 | 1 | 1 | 1 | 2 |
| CHE | CHEMED CORP | -869,757 | -$79.09M | 0 | 1 | 2 | 1 | 3 |
| CNC | CENTENE CORP | -865,277 | -$65.21M | 0 | 0 | 1 | 1 | 1 |
| SNY | SANOFI-ADR | -756,505 | $129.69M | 0 | 2 | 3 | 0 | 9 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | -671,424 | -$77.78M | 0 | 3 | 4 | 1 | 8 |
| LFCR | LIFECORE BIOMEDICAL INC | -608,571 | -$8.04M | 0 | 0 | 2 | 0 | 2 |
| BAX | BAXTER INTERNATIONAL INC | -515,262 | -$41.05M | 0 | 2 | 4 | 1 | 7 |
| A | AGILENT TECHNOLOGIES INC | -455,909 | -$28.33M | 1 | 2 | 1 | 0 | 5 |
| ACAD | ACADIA PHARMACEUTICALS INC | -432,988 | -$396.00K | 0 | 0 | 1 | 0 | 1 |
| WST | WEST PHARMACEUTICAL SERVICES | -354,300 | -$11.71M | 0 | 0 | 1 | 0 | 1 |
| DHR | DANAHER CORP | -331,599 | -$32.48M | 1 | 3 | 0 | 1 | 4 |
| ALGN | ALIGN TECHNOLOGY INC | -328,248 | -$25.61M | 0 | 1 | 1 | 1 | 2 |
| UTMD | UTAH MEDICAL PRODUCTS INC | -303,267 | -$15.84M | 0 | 1 | 0 | 1 | 1 |
| SIGA | SIGA TECHNOLOGIES INC | -286,205 | -$807.00K | 0 | 0 | 0 | 1 | 0 |
| RDNT | RADNET INC | -266,100 | -$1.77M | 0 | 0 | 1 | 0 | 1 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | -264,521 | -$9.77M | 0 | 0 | 1 | 0 | 1 |
| RHHBY | ROCHE HOLDINGS LTD-SPONS ADR | -243,714 | -$9.92M | 0 | 1 | 1 | 0 | 2 |
| LLY | ELI LILLY & CO | -242,886 | $3.23M | 1 | 1 | 3 | 1 | 6 |
| GILD | GILEAD SCIENCES INC | -211,374 | $249.07M | 2 | 7 | 3 | 1 | 13 |
| AMRN | AMARIN CORP PLC -ADR | -184,200 | -$324.00K | 0 | 0 | 0 | 1 | 0 |
| MMSI | MERIT MEDICAL SYSTEMS INC | -179,944 | -$2.72M | 0 | 0 | 0 | 1 | 0 |
| OMCL | OMNICELL INC | -178,879 | -$5.36M | 0 | 0 | 2 | 0 | 2 |
| HAE | HAEMONETICS CORP/MASS | -178,100 | -$6.30M | 0 | 0 | 1 | 0 | 1 |
| RVTY | REVVITY INC | -170,800 | -$8.00M | 0 | 0 | 0 | 1 | 0 |
| PODD | INSULET CORP | -167,200 | -$6.63M | 0 | 0 | 0 | 1 | 0 |
| GRFS | GRIFOLS SA-ADR | -161,800 | -$10.38M | 0 | 0 | 1 | 0 | 1 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -156,600 | -$16.27M | 0 | 1 | 0 | 1 | 2 |
| FMS | FRESENIUS MEDICAL CARE-ADR | -132,000 | -$4.32M | 0 | 0 | 1 | 0 | 1 |
| CAH | CARDINAL HEALTH INC | -121,225 | -$7.27M | 0 | 1 | 0 | 1 | 2 |
| HBIO | HARVARD BIOSCIENCE INC | -108,300 | -$784.00K | 0 | 0 | 1 | 0 | 1 |
| PETS | PETMED EXPRESS INC | -106,192 | -$1.24M | 0 | 0 | 1 | 0 | 1 |
| ANIK | ANIKA THERAPEUTICS INC | -96,800 | -$7.10M | 0 | 0 | 1 | 0 | 1 |
| ANIP | ANI PHARMACEUTICALS INC | -89,300 | -$3.25M | 0 | 0 | 1 | 0 | 1 |
| AMED | AMEDISYS INC | -79,100 | -$434.00K | 0 | 0 | 1 | 0 | 1 |
| CCRN | CROSS COUNTRY HEALTHCARE INC | -73,400 | -$58.00K | 0 | 0 | 1 | 0 | 1 |
| EBS | EMERGENT BIOSOLUTIONS INC | -68,100 | -$2.15M | 0 | 0 | 1 | 0 | 1 |
| ICUI | ICU MEDICAL INC | -64,889 | -$1.99M | 1 | 0 | 1 | 0 | 2 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -62,130 | -$296.00K | 0 | 1 | 2 | 1 | 4 |
| TFX | TELEFLEX INC | -61,773 | -$7.82M | 0 | 1 | 2 | 0 | 4 |
| ALKS | ALKERMES PLC | -58,900 | -$4.13M | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q3 2014
What are the most sold Healthcare stocks in Q3 2014?
The most sold healthcare stocks in Q3 2014 are those with the largest decrease in reported share counts across institutional investors compared to Q2 2014, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q3 2014?
Among filers in this sector, net reductions were largest in companies such as PFIZER INC (PFE), ABBOTT LABORATORIES (ABT), BRISTOL-MYERS SQUIBB CO (BMY), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2014).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.